This fund gives investors exposure to companies at the forefront of medical innovation — from next-gen diagnostics and robotic surgery to gene editing and biotech research. It tracks the performance of global firms developing disruptive healthcare technologies, offering a passive, simple and diversified way to invest in the evolution of modern medicine.
This fund tracks the STOXX Global Breakthrough Healthcare Index, which includes companies that derive a significant portion of their revenue from healthcare innovation themes, such as:
Companies in the index must meet certain criteria, and weight caps are applied to prevent over-concentration in particular companies.
This is primarily a thematic fund, as it targets a specific investment theme. It does track an index, making it a passively managed fund, but its index is rule-based, rather than tracking a specific section of the market (like the S&P 500).
Thematic investments don’t tend to give broad market exposure on their own, so should form part of a diverse portfolio.
HSBC Asset Management is part of the wider HSBC Group, boasting over 50 years experience and managing $600 billion (2024).
HSBC focuses on bringing investors a low-cost range of investment products, with particular strength in global equity and ESG offerings.
VanEck is a privately-held global investment manager with 70 years experience and $114 billion in assets under management (as of mid-2024). Over the last 19 years, VanEck has pioneered over 100 specialty ETFs across a range of innovative thematic sectors such as gold, semiconductors, emerging markets, gaming and others.
iShares ETFs are managed by BlackRock, the world’s largest asset manager, with over three decades of experience in index investing. The team applies rigorous quantitative research and disciplined risk management to deliver diversified, cost-effective market exposure.
With a strong emphasis on transparency and innovation, iShares products are built to support efficient, long-term investment strategies.
BlackRock is the world’s largest asset manager. Founded in 1988, it provides a wide range of investment products and services to institutions, financial professionals, and individual investors worldwide.
Invesco is a global asset manager with over $1.4 trillion in assets (2024). They offer over 240 ETFs, covering equities, fixed income, commodities and thematics.
Founded in 1935, Invesco brings 90 years of experience creating reliable, investor-first solutions.
Vanguard has been providing investment solutions to everyday investors since the 1970s. Today, it manages $10 trillion for over 50 million investors worldwide (2024), sticking to a philosophy of low costs, transparency, and long-term thinking.
State Street Investment Management launched its first ETF in 1993, and has been managing client assets for 47 years. As of March 2025, State Street’s Investment Management division holds $4.67 trillion in assets under management, is the third largest ETF provider and fourth largest asset manager in the world.
This copy is for legal and general
WisdomTree is a global asset manager based in New York. With $116 billion under management (as of April 2025), they are a trusted provider of over 260 ETPs (Exchange Traded Products).
Their investment product philosophy seeks to use unique research to provide investors access to traditionally inaccessible asset classes.
A global healthcare company providing diagnostics, medical devices, nutrition products, and branded generic medicines.
Designs and manufactures medical devices used in minimally invasive procedures across cardiology, neurology, and more.
Develops advanced DNA sequencing and genomics solutions used in research, diagnostics, and precision medicine.
Specialises in tubeless insulin pump technology for people with diabetes, including the popular Omnipod system.
Biopharma company focused on treatments for neurological and endocrine disorders.
A Belgian biopharmaceutical company focused on treating severe neurological and immunological diseases.
No hidden fees, or fees that will grow over time. You won’t pay more to invest more with Chip X.*
We keep it simple with a curated range of funds from some of the world’s biggest asset managers.
Set up recurring deposits directly into your chosen funds and save the payday admin.
Our Dual Track feature lets you choose from three risk levels, or create your own portfolio from a curated range of funds.
Step 1
Enjoy tax-free returns with a Stocks & Shares ISA and invest without limits with a General Investment Account.
Step 2
Choose to do it yourself and pick your own funds, or choose from our three ready-made options.
Step 3
Easily access your portfolio at your fingertips, and set up recurring deposits to build wealth for the future.
Avg. annual returns
27/06/2020 - 27/06/2025
+
9.37%
-
9.37%
Fund Provider
iShares
Management Charges
0.40%
Risk level
7 of 7
Category
Thematic
Region
Global
Avg. annual returns
27/06/2020 - 27/06/2025
+
8.24%
-
8.24%
Fund Provider
Amundi
Management Charges
0.25
Risk level
7 of 7
Category
Thematic
Region
Global
Avg. annual returns
27/06/2024 - 27/06/2025
+
4.31%
-
4.31%
Fund Provider
WisdomTree
Management Charges
0.50%
Risk level
7 of 7
Category
Thematic
Region
Global
Avg. annual returns
27/06/2020 - 27/06/2025
+
0.45%
-
0.45%
Fund Provider
iShares
Management Charges
0.65%
Risk level
7 of 7
Category
Thematic
Region
Global
As populations age and technology advances, demand for improved treatments and diagnostics is expected to rise. Thematic investments can be more volatile and potentially fluctuate depending on global demand and supply issues.
This ETF provides some diversification by tracking various companies within an index. It is still a thematic fund, so investors may want to consider diversifying portfolio risk across multiple sectors.
Yes, the iShares Healthcare Innovation UCITS ETF is available to UK investors, as it’s compliant with EU UCITS regulations.
While ESG isn’t the fund's primary focus, it does benefit from evaluation and alignment with iShares’ basic ESG standards.
While ESG isn’t the fund's primary focus, it does benefit from evaluation and alignment with iShares’ basic ESG standards.
Scan the QR code below to download the Chip app and get started.
or get a download link via email.
